{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease (AD)", "Cholinesterase inhibitors", "Electroencephalography (EEG)", "Systematic review"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37843690", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1007/s10072-023-07114-y"], "Journal": {"ISSN": "1590-3478", "JournalIssue": {"Volume": "45", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Feb"}}, "Title": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology", "ISOAbbreviation": "Neurol Sci"}, "ArticleTitle": "The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review.", "Pagination": {"StartPage": "417", "EndPage": "430", "MedlinePgn": "417-430"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common type of dementia. The early diagnosis of AD is an important factor for the control of AD progression. Electroencephalography (EEG) can be used for early diagnosis of AD. Acetylcholinesterase inhibitors (AChEIs) are also used for the amelioration of AD symptoms. In this systematic review, we reviewed the effect of different AChEIs including donepezil, rivastigmine, tacrine, physostigmine, and galantamine on EEG patterns in patients with AD.", "PubMed electronic database was searched and 122 articles were found. After removal of unrelated articles, 24 articles were selected for the present study.", "AChEIs can decrease beta, theta, and delta frequency bands in patients with AD. However, conflicting results were found for alpha band. Some studies have shown increased alpha frequency, while others have shown decreased alpha frequency following treatment with AChEIs. The only difference was the type of drug.", "We found that studies reporting the decreased alpha frequency used donepezil and galantamine, while studies reporting the increased alpha frequency used rivastigmine and tacrine. It was suggested that future studies should focus on the effect of different AChEIs on EEG bands, especially alpha frequency in patients with AD, to compare their effects and find the reason for their different influence on EEG patterns. Also, differences between the effects of AChEIs on oligodendrocyte differentiation and myelination may be another important factor. This is the first article investigating the effect of different AChEIs on EEG patterns in patients with AD."], "CopyrightInformation": "\u00a9 2023. Fondazione Societ\u00e0 Italiana di Neurologia."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Cognitive & Brain Sciences, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Arjmandi-Rad", "ForeName": "Shirin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Science and Technology, Aalborg University, Aalborg, Denmark."}], "LastName": "Vestergaard Nieland", "ForeName": "John D", "Initials": "JD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KaRa Institute of Neurological Diseases Pty Ltd, Macquarie, NSW, Australia."}, {"Identifier": [], "Affiliation": "Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia."}], "LastName": "Goozee", "ForeName": "Kathryn G", "Initials": "KG"}, {"Identifier": ["0000-0002-2436-9887"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cognitive Neuroscience Lab, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. vaseghi@imp.ac.ir."}], "LastName": "Vaseghi", "ForeName": "Salar", "Initials": "S"}], "PublicationTypeList": ["Systematic Review", "Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Neurol Sci", "NlmUniqueID": "100959175", "ISSNLinking": "1590-1874"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "8SSC91326P", "NameOfSubstance": "Donepezil"}, {"RegistryNumber": "PKI06M3IW0", "NameOfSubstance": "Rivastigmine"}, {"RegistryNumber": "0D3Q044KCA", "NameOfSubstance": "Galantamine"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "4VX7YNB537", "NameOfSubstance": "Tacrine"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Indans"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenylcarbamates"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Donepezil"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Rivastigmine"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Galantamine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Tacrine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Piperidines"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Indans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phenylcarbamates"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Yang H, Jeong Y (2021) Correlation between Alteration of Sharp-wave Ripple Coupled Cortical Oscillation and Long-term Memory Deficit in Alzheimer Disease Model Mice. Exp Neurobiol 30(6):430\u2013440. https://doi.org/10.5607/en21046", "ArticleIdList": ["10.5607/en21046", "34983883", "8752320"]}, {"Citation": "Smailovic U, Jelic V (2019) Neurophysiological Markers of Alzheimer\u2019s Disease: Quantitative EEG Approach. Neurol Ther 8(Suppl 2):37\u201355. https://doi.org/10.1007/s40120-019-00169-0", "ArticleIdList": ["10.1007/s40120-019-00169-0", "31833023", "6908537"]}, {"Citation": "Anwar MM (2021) Brain-printing biometrics underlying mechanism as an early diagnostic technique for Alzheimer\u2019s disease neurodegenerative type. Curr Res Physiol 4:216\u2013222. https://doi.org/10.1016/j.crphys.2021.09.005", "ArticleIdList": ["10.1016/j.crphys.2021.09.005", "34746841", "8562242"]}, {"Citation": "Blank RH (2019) Alzheimer\u2019s Disease and Other Dementias: An Introduction. In: Social & Public Policy of Alzheimer's Disease in the United States. Springer, pp 1\u201326"}, {"Citation": "Pause BM, Zlomuzica A, Kinugawa K, Mariani J, Pietrowsky R, Dere E (2013) Perspectives on episodic-like and episodic memory. Front Behav Neurosci 7:33. https://doi.org/10.3389/fnbeh.2013.00033", "ArticleIdList": ["10.3389/fnbeh.2013.00033", "23616754", "3629296"]}, {"Citation": "Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33. https://doi.org/10.1038/s41572-021-00269-y", "ArticleIdList": ["10.1038/s41572-021-00269-y", "33986301", "8574196"]}, {"Citation": "Houmani N, Vialatte F, Gallego-Jutgla E, Dreyfus G, Nguyen-Michel VH, Mariani J, Kinugawa K (2018) Diagnosis of Alzheimer\u2019s disease with Electroencephalography in a differential framework. PLoS ONE 13(3):e0193607. https://doi.org/10.1371/journal.pone.0193607", "ArticleIdList": ["10.1371/journal.pone.0193607", "29558517", "5860733"]}, {"Citation": "Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet 388(10043):505\u2013517. https://doi.org/10.1016/S0140-6736(15)01124-1", "ArticleIdList": ["10.1016/S0140-6736(15)01124-1", "26921134"]}, {"Citation": "Sun J, Wang B, Niu Y, Tan Y, Fan C, Zhang N, Xue J, Wei J, Xiang J (2020) Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer's Disease: A Review. Entropy (Basel) 22(2). https://doi.org/10.3390/e22020239"}, {"Citation": "Schaul N (1998) The fundamental neural mechanisms of electroencephalography. Electroencephalogr Clin Neurophysiol 106(2):101\u2013107. https://doi.org/10.1016/s0013-4694(97)00111-9", "ArticleIdList": ["10.1016/s0013-4694(97)00111-9", "9741769"]}, {"Citation": "Buskila Y, Bellot-Saez A, Morley JW (2019) Generating Brain Waves, the Power of Astrocytes. Front Neurosci 13:1125. https://doi.org/10.3389/fnins.2019.01125", "ArticleIdList": ["10.3389/fnins.2019.01125", "31680846", "6813784"]}, {"Citation": "Sanchez-Vives MV, McCormick DA (2000) Cellular and network mechanisms of rhythmic recurrent activity in neocortex. Nat Neurosci 3(10):1027\u20131034. https://doi.org/10.1038/79848", "ArticleIdList": ["10.1038/79848", "11017176"]}, {"Citation": "Cossart R, Aronov D, Yuste R (2003) Attractor dynamics of network UP states in the neocortex. Nature 423(6937):283\u2013288. https://doi.org/10.1038/nature01614", "ArticleIdList": ["10.1038/nature01614", "12748641"]}, {"Citation": "Fries P (2005) A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci 9(10):474\u2013480. https://doi.org/10.1016/j.tics.2005.08.011", "ArticleIdList": ["10.1016/j.tics.2005.08.011", "16150631"]}, {"Citation": "Penttonen M, Buzs\u00e1ki G (2003) Natural logarithmic relationship between brain oscillators. Thalamus Relat Syst 2(2):145\u2013152", "ArticleIdList": ["10.1017/S1472928803000074"]}, {"Citation": "Singer W (1993) Synchronization of cortical activity and its putative role in information processing and learning. Annu Rev Physiol 55:349\u2013374. https://doi.org/10.1146/annurev.ph.55.030193.002025", "ArticleIdList": ["10.1146/annurev.ph.55.030193.002025", "8466179"]}, {"Citation": "Bellot-Saez A, Cohen G, van Schaik A, Ooi L, Morley JW, Buskila Y (2018) Astrocytic modulation of cortical oscillations. Sci Rep 8(1):11565. https://doi.org/10.1038/s41598-018-30003-w", "ArticleIdList": ["10.1038/s41598-018-30003-w", "30068965", "6070488"]}, {"Citation": "Ainsworth M, Lee S, Cunningham MO, Roopun AK, Traub RD, Kopell NJ, Whittington MA (2011) Dual gamma rhythm generators control interlaminar synchrony in auditory cortex. J Neurosci 31(47):17040\u201317051", "ArticleIdList": ["10.1523/JNEUROSCI.2209-11.2011", "22114273", "3654396"]}, {"Citation": "Steriade M, McCormick DA, Sejnowski TJ (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262(5134):679\u2013685", "ArticleIdList": ["10.1126/science.8235588", "8235588"]}, {"Citation": "Tohidi V, Nadim F (2009) Membrane resonance in bursting pacemaker neurons of an oscillatory network is correlated with network frequency. J Neurosci 29(20):6427\u20136435", "ArticleIdList": ["10.1523/JNEUROSCI.0545-09.2009", "19458214", "2716082"]}, {"Citation": "Contreras D, Llinas R (2001) Voltage-sensitive dye imaging of neocortical spatiotemporal dynamics to afferent activation frequency. J Neurosci 21(23):9403\u20139413. https://doi.org/10.1523/JNEUROSCI.21-23-09403.2001", "ArticleIdList": ["10.1523/JNEUROSCI.21-23-09403.2001", "11717373", "6763902"]}, {"Citation": "He BJ, Snyder AZ, Zempel JM, Smyth MD, Raichle ME (2008) Electrophysiological correlates of the brain\u2019s intrinsic large-scale functional architecture. Proc Natl Acad Sci U S A 105(41):16039\u201316044. https://doi.org/10.1073/pnas.0807010105", "ArticleIdList": ["10.1073/pnas.0807010105", "18843113", "2564983"]}, {"Citation": "Murthy VN, Fetz EE (1992) Coherent 25- to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys. Proc Natl Acad Sci U S A 89(12):5670\u20135674. https://doi.org/10.1073/pnas.89.12.5670", "ArticleIdList": ["10.1073/pnas.89.12.5670", "1608977", "49354"]}, {"Citation": "Achermann P, Borbely AA (1997) Low-frequency (< 1 Hz) oscillations in the human sleep electroencephalogram. Neuroscience 81(1):213\u2013222. https://doi.org/10.1016/s0306-4522(97)00186-3", "ArticleIdList": ["10.1016/s0306-4522(97)00186-3", "9300413"]}, {"Citation": "Brooks DC (1968) Waves associated with eye movement in the awake and sleeping cat. Electroencephalogr Clin Neurophysiol 24(6):532\u2013541. https://doi.org/10.1016/0013-4694(68)90042-4", "ArticleIdList": ["10.1016/0013-4694(68)90042-4", "4172737"]}, {"Citation": "Buzsaki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 304(5679):1926\u20131929. https://doi.org/10.1126/science.1099745", "ArticleIdList": ["10.1126/science.1099745", "15218136"]}, {"Citation": "Isomura Y, Sirota A, Ozen S, Montgomery S, Mizuseki K, Henze DA, Buzsaki G (2006) Integration and segregation of activity in entorhinal-hippocampal subregions by neocortical slow oscillations. Neuron 52(5):871\u2013882. https://doi.org/10.1016/j.neuron.2006.10.023", "ArticleIdList": ["10.1016/j.neuron.2006.10.023", "17145507"]}, {"Citation": "Tsolaki A, Kazis D, Kompatsiaris I, Kosmidou V, Tsolaki M (2014) Electroencephalogram and Alzheimer\u2019s disease: clinical and research approaches. Int J Alzheimers Dis 2014:349249. https://doi.org/10.1155/2014/349249", "ArticleIdList": ["10.1155/2014/349249", "24868482", "4020452"]}, {"Citation": "McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100. https://doi.org/10.1212/WNL.0000000000004058", "ArticleIdList": ["10.1212/WNL.0000000000004058", "28592453", "5496518"]}, {"Citation": "Pijnenburg YAL, Strijers RLM, Made YV, van der Flier WM, Scheltens P, Stam CJ (2008) Investigation of resting-state EEG functional connectivity in frontotemporal lobar degeneration. Clin Neurophysiol 119(8):1732\u20131738. https://doi.org/10.1016/j.clinph.2008.02.024", "ArticleIdList": ["10.1016/j.clinph.2008.02.024", "18490193"]}, {"Citation": "Briels CT, Stam CJ, Scheltens P, Gouw AA (2021) The predictive value of normal EEGs in dementia due to Alzheimer\u2019s disease. Ann Clin Transl Neurol 8(5):1038\u20131048. https://doi.org/10.1002/acn3.51339", "ArticleIdList": ["10.1002/acn3.51339", "33835723", "8108419"]}, {"Citation": "Law ZK, Todd C, Mehraram R, Schumacher J, Baker MR, LeBeau FEN, Yarnall A, Onofrj M, Bonanni L, Thomas A, Taylor JP (2020) The Role of EEG in the Diagnosis, Prognosis and Clinical Correlations of Dementia with Lewy Bodies-A Systematic Review. Diagnostics (Basel) 10(9). https://doi.org/10.3390/diagnostics10090616"}, {"Citation": "Jeong J (2004) EEG dynamics in patients with Alzheimer\u2019s disease. Clin Neurophysiol 115(7):1490\u20131505. https://doi.org/10.1016/j.clinph.2004.01.001", "ArticleIdList": ["10.1016/j.clinph.2004.01.001", "15203050"]}, {"Citation": "Cassani R, Estarellas M, San-Martin R, Fraga FJ, Falk TH (2018) Systematic Review on Resting-State EEG for Alzheimer\u2019s Disease Diagnosis and Progression Assessment. Dis Markers 2018:5174815. https://doi.org/10.1155/2018/5174815", "ArticleIdList": ["10.1155/2018/5174815", "30405860", "6200063"]}, {"Citation": "Radic B, Petrovic R, Golubic A, Bilic E, Borovecki F (2019) EEG Analysis and Spect Imaging in Alzheimer\u2019s Disease, Vascular Dementia and Mild Cognitive Impairment. Psychiatr Danub 31(1):111\u2013115. https://doi.org/10.24869/psyd.2019.111", "ArticleIdList": ["10.24869/psyd.2019.111", "30948698"]}, {"Citation": "Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, Wahlund LO (1996) Quantitative electroencephalography power and coherence in Alzheimer\u2019s disease and mild cognitive impairment. Dementia 7(6):314\u2013323. https://doi.org/10.1159/000106897", "ArticleIdList": ["10.1159/000106897", "8915037"]}, {"Citation": "Babiloni C, Ferri R, Moretti DV, Strambi A, Binetti G, Dal Forno G, Ferreri F, Lanuzza B, Bonato C, Nobili F, Rodriguez G, Salinari S, Passero S, Rocchi R, Stam CJ, Rossini PM (2004) Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer\u2019s disease: a multicentric EEG study. Eur J Neurosci 19(9):2583\u20132590. https://doi.org/10.1111/j.0953-816X.2004.03333.x", "ArticleIdList": ["10.1111/j.0953-816X.2004.03333.x", "15128412"]}, {"Citation": "Gouw AA, Alsema AM, Tijms BM, Borta A, Scheltens P, Stam CJ, van der Flier WM (2017) EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects. Neurobiol Aging 57:133\u2013142. https://doi.org/10.1016/j.neurobiolaging.2017.05.017", "ArticleIdList": ["10.1016/j.neurobiolaging.2017.05.017", "28646686"]}, {"Citation": "Ihl R, Dierks T, Martin EM, Froolich L, Maurer K (1996) Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biol Psychiatry 39(5):319\u2013325. https://doi.org/10.1016/0006-3223(95)00174-3", "ArticleIdList": ["10.1016/0006-3223(95)00174-3", "8704062"]}, {"Citation": "Vialatte FB, Dauwels J, Maurice M, Musha T, Cichocki A (2011) Improving the specificity of EEG for diagnosing Alzheimer\u2019s disease. Int J Alzheimers Dis 2011:259069. https://doi.org/10.4061/2011/259069", "ArticleIdList": ["10.4061/2011/259069", "21660242", "3109519"]}, {"Citation": "Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD, Group DS (2001) Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 58(3):427\u2013433", "ArticleIdList": ["10.1001/archneur.58.3.427", "11255446"]}, {"Citation": "Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352(23):2379\u20132388", "ArticleIdList": ["10.1056/NEJMoa050151", "15829527"]}, {"Citation": "Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL (2004) Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical \u201cdisconnection\u201d in aging and Alzheimer\u2019s disease. Neurobiol Aging 25(7):843\u2013851", "ArticleIdList": ["10.1016/j.neurobiolaging.2003.09.005", "15212838"]}, {"Citation": "Kemper TL (1994) Neuroanatomical and neuropathological changes during aging and dementia. In: Albert ML,\u00a0Knoefel JE (eds.) Clinical neurology of aging. Oxford University Press, pp. 3\u201367"}, {"Citation": "Bartzokis G (2007) Acetylcholinesterase inhibitors may improve myelin integrity. Biol Psychiat 62(4):294\u2013301", "ArticleIdList": ["10.1016/j.biopsych.2006.08.020", "17070782"]}, {"Citation": "Pimlott S, Piggott M, Owens J, Greally E, Court J, Jaros E, Perry R, Perry E, Wyper D (2004) Nicotinic acetylcholine receptor distribution in Alzheimer\u2019s disease, dementia with Lewy bodies, Parkinson\u2019s disease, and vascular dementia: in vitro binding study using 5-[125I]-A-85380. Neuropsychopharmacology 29(1):108\u2013116", "ArticleIdList": ["10.1038/sj.npp.1300302", "12955099"]}, {"Citation": "Imamura O, Arai M, Dateki M, Oishi K, Takishima K (2020) Donepezil-induced oligodendrocyte differentiation is mediated through estrogen receptors. J Neurochem 155(5):494\u2013507", "ArticleIdList": ["10.1111/jnc.14927", "31778582"]}, {"Citation": "Imamura O, Arai M, Dateki M, Takishima K (2017) Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis. J Neurochem 140(2):231\u2013244", "ArticleIdList": ["10.1111/jnc.13856", "27664791"]}, {"Citation": "Cui X, Guo Y-e, Fang J-h, Shi C-j, Suo N, Zhang R, Xie X (2019) Donepezil, a drug for Alzheimer\u2019s disease, promotes oligodendrocyte generation and remyelination. Acta Pharmacol Sin 40(11):1386\u20131393", "ArticleIdList": ["10.1038/s41401-018-0206-4", "30918344", "6888883"]}, {"Citation": "Kotani S, Yamauchi T, Teramoto T, Ogura H (2006) Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 142(2):505\u2013514", "ArticleIdList": ["10.1016/j.neuroscience.2006.06.035", "16889901"]}, {"Citation": "Kita Y, Ago Y, Higashino K, Asada K, Takano E, Takuma K, Matsuda T (2014) Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and \u03b1 7 nicotinic receptors in mice. Int J Neuropsychopharmacol 17(12):1957\u20131968", "ArticleIdList": ["10.1017/S1461145714000613", "24818616"]}, {"Citation": "Ahnaou A, Huysmans H, Jacobs T, Drinkenburg WH (2014) Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential. Neuropharmacology 86:362\u2013377. https://doi.org/10.1016/j.neuropharm.2014.08.015", "ArticleIdList": ["10.1016/j.neuropharm.2014.08.015", "25181033"]}, {"Citation": "Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ (2021) Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer\u2019s disease. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.15206", "ArticleIdList": ["10.1111/bcp.15206"]}, {"Citation": "Brassen S, Adler G (2003) Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry 36(6):304\u2013308. https://doi.org/10.1055/s-2003-45118", "ArticleIdList": ["10.1055/s-2003-45118", "14663655"]}, {"Citation": "Moretti DV, Frisoni GB, Binetti G, Zanetti O (2014) Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer\u2019s disease. Front Aging Neurosci 6:179. https://doi.org/10.3389/fnagi.2014.00179", "ArticleIdList": ["10.3389/fnagi.2014.00179", "25100996", "4107674"]}, {"Citation": "Reeves RR, Struve FA, Patrick G (2002) The effects of donepezil on quantitative EEG in patients with Alzheimer\u2019s disease. Clin Electroencephalogr 33(2):93\u201396. https://doi.org/10.1177/155005940203300209", "ArticleIdList": ["10.1177/155005940203300209", "12025738"]}, {"Citation": "Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71", "ArticleIdList": ["10.1136/bmj.n71", "33782057", "8005924"]}, {"Citation": "Naomi R, Ardhani R, Hafiyyah OA, Fauzi MB (2020) Current Insight of Collagen Biomatrix for Gingival Recession: An Evidence-Based Systematic Review. Polymers (Basel) 12(9). https://doi.org/10.3390/polym12092081"}, {"Citation": "Moretti DV (2014) Alpha rhythm oscillations and MMSE scores are differently modified by transdermal or oral rivastigmine in patients with Alzheimer\u2019s disease. Am J Neurodegener Dis 3(2):72\u201383", "ArticleIdList": ["25232512", "4162588"]}, {"Citation": "Gianotti LR, Kunig G, Faber PL, Lehmann D, Pascual-Marqui RD, Kochi K, Schreiter-Gasser U (2008) Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer\u2019s disease. Psychopharmacology 198(3):323\u2013332. https://doi.org/10.1007/s00213-008-1111-1", "ArticleIdList": ["10.1007/s00213-008-1111-1", "18446328"]}, {"Citation": "Adler G, Brassen S, Chwalek K, Dieter B, Teufel M (2004) Prediction of treatment response to rivastigmine in Alzheimer\u2019s dementia. J Neurol Neurosurg Psychiatry 75(2):292\u2013294", "ArticleIdList": ["14742608", "1738912"]}, {"Citation": "Adler G, Brassen S (2001) Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients. Neuropsychobiology 43(4):273\u2013276. https://doi.org/10.1159/000054902", "ArticleIdList": ["10.1159/000054902", "11340368"]}, {"Citation": "Gustafson L, Edvinsson L, Dahlgren N, Hagberg B, Risberg J, Rosen I, Ferno H (1987) Intravenous physostigmine treatment of Alzheimer\u2019s disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology 93(1):31\u201335. https://doi.org/10.1007/BF02439583", "ArticleIdList": ["10.1007/BF02439583", "3114812"]}, {"Citation": "Agnoli A, Martucci N, Manna V, Conti L, Fioravanti M (1983) Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer\u2019s dementia: a neuropsychological and computerized electroencephalographic study. Clin Neuropharmacol 6(4):311\u2013323. https://doi.org/10.1097/00002826-198312000-00005", "ArticleIdList": ["10.1097/00002826-198312000-00005", "6661730"]}, {"Citation": "Moraes Wdos S, Poyares DR, Guilleminault C, Ramos LR, Bertolucci PH, Tufik S (2006) The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Sleep 29(2):199\u2013205. https://doi.org/10.1093/sleep/29.2.199", "ArticleIdList": ["10.1093/sleep/29.2.199", "16494088"]}, {"Citation": "Kai T, Asai Y, Sakuma K, Koeda T, Nakashima K (2005) Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer\u2019s disease. J Neurol Sci 237(1\u20132):89\u201395. https://doi.org/10.1016/j.jns.2005.05.017", "ArticleIdList": ["10.1016/j.jns.2005.05.017", "16019033"]}, {"Citation": "Balkan S, Yaras N, Mihci E, Dora B, Agar A, Yargicoglu P (2003) Effect of donepezil on EEG spectral analysis in Alzheimer\u2019s disease. Acta Neurol Belg 103(3):164\u2013169", "ArticleIdList": ["14626697"]}, {"Citation": "Almkvist O, Jelic V, Amberla K, Hellstrom-Lindahl E, Meurling L, Nordberg A (2001) Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dement Geriatr Cogn Disord 12(1):22\u201332. https://doi.org/10.1159/000051232", "ArticleIdList": ["10.1159/000051232", "11125238"]}, {"Citation": "Knott V, Mohr E, Mahoney C, Ilivitsky V (2000) Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer\u2019s disease. Methods Find Exp Clin Pharmacol 22(2):115\u2013122. https://doi.org/10.1358/mf.2000.22.2.796074", "ArticleIdList": ["10.1358/mf.2000.22.2.796074", "10849895"]}, {"Citation": "Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A (1998) Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer\u2019s disease. Neurosci Lett 254(2):85\u201388. https://doi.org/10.1016/s0304-3940(98)00669-7", "ArticleIdList": ["10.1016/s0304-3940(98)00669-7", "9779926"]}, {"Citation": "Riekkinen P Jr, Soininen H, Partanen J, Paakkonen A, Helisalmi S, Riekkinen P Sr (1997) The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients. Psychopharmacology 129(3):285\u2013288. https://doi.org/10.1007/s002130050192", "ArticleIdList": ["10.1007/s002130050192", "9084068"]}, {"Citation": "Minthon L, Gustafson L, Dalfelt G, Hagberg B, Nilsson K, Risberg J, Rosen I, Seiving B, Wendt PE (1993) Oral tetrahydroaminoacridine treatment of Alzheimer\u2019s disease evaluated clinically and by regional cerebral blood flow and EEG. Dementia 4(1):32\u201342. https://doi.org/10.1159/000107293", "ArticleIdList": ["10.1159/000107293", "8358504"]}, {"Citation": "Shigeta M, Persson A, Viitanen M, Winblad B, Nordberg A (1993) EEG regional changes during long-term treatment with tetrahydroaminoacridine (THA) in Alzheimer\u2019s disease. Acta Neurol Scand Suppl 149:58\u201361. https://doi.org/10.1111/j.1600-0404.1993.tb04258.x", "ArticleIdList": ["10.1111/j.1600-0404.1993.tb04258.x", "8128842"]}, {"Citation": "Gustafson L (1993) Physostigmine and tetrahydroaminoacridine treatment of Alzheimer\u2019s disease. Acta Neurol Scand Suppl 149(Rand):39\u201341. https://doi.org/10.1111/j.1600-0404.1993.tb04253.x", "ArticleIdList": ["10.1111/j.1600-0404.1993.tb04253.x", "8128836"]}, {"Citation": "Alhainen K, Riekkinen PJ Sr (1993) Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy. Acta Neurol Scand Suppl 149:16\u201321. https://doi.org/10.1111/j.1600-0404.1993.tb04248.x", "ArticleIdList": ["10.1111/j.1600-0404.1993.tb04248.x", "7907454"]}, {"Citation": "Perryman KM, Fitten LJ (1991) Quantitative EEG during a double-blind trial of THA and lecithin in patients with Alzheimer\u2019s disease. J Geriatr Psychiatry Neurol 4(3):127\u2013133. https://doi.org/10.1177/089198879100400302", "ArticleIdList": ["10.1177/089198879100400302", "1953964"]}, {"Citation": "Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P (1991) Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer\u2019s disease. Neurosci Lett 127(1):113\u2013116. https://doi.org/10.1016/0304-3940(91)90907-b", "ArticleIdList": ["10.1016/0304-3940(91)90907-b", "1881606"]}, {"Citation": "Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190:108352. https://doi.org/10.1016/j.neuropharm.2020.108352", "ArticleIdList": ["10.1016/j.neuropharm.2020.108352", "33035532"]}, {"Citation": "Babiloni C, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Hirata K, Lanuzza B (2006) Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study. Clin Neurophysiol 117(2):252\u2013268", "ArticleIdList": ["10.1016/j.clinph.2005.09.019", "16377238"]}, {"Citation": "Babiloni C, Pievani M, Vecchio F, Geroldi C, Eusebi F, Fracassi C, Fletcher E, De Carli C, Boccardi M, Rossini PM (2009) White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment. Hum Brain Mapp 30(5):1431\u20131443", "ArticleIdList": ["10.1002/hbm.20612", "19097164"]}, {"Citation": "Klimesch W (1999) EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev 29(2\u20133):169\u2013195. https://doi.org/10.1016/s0165-0173(98)00056-3", "ArticleIdList": ["10.1016/s0165-0173(98)00056-3", "10209231"]}, {"Citation": "Nunez PL, Reid L, Bickford RG (1978) The relationship of head size to alpha frequency with implications to a brain wave model. Electroencephalogr Clin Neurophysiol 44(3):344\u2013352", "ArticleIdList": ["10.1016/0013-4694(78)90309-7", "76540"]}, {"Citation": "Klimesch W, Schimke H, Pfurtscheller G (1993) Alpha frequency, cognitive load and memory performance. Brain Topogr 5(3):241\u2013251", "ArticleIdList": ["10.1007/BF01128991", "8507550"]}, {"Citation": "Yener GG, Emek-Sava\u015f DD, Lizio R, \u00c7avu\u015fo\u011flu B, Carducci F, Ada E, G\u00fcntekin B, Babiloni CC, Ba\u015far E (2016) Frontal delta event-related oscillations relate to frontal volume in mild cognitive impairment and healthy controls. Int J Psychophysiol 103:110\u2013117", "ArticleIdList": ["10.1016/j.ijpsycho.2015.02.005", "25660300"]}, {"Citation": "Kipi\u0144ski L, K\u00f6nig R, Sielu\u017cycki C, Kordecki W (2011) Application of modern tests for stationarity to single-trial MEG data: transferring powerful statistical tools from econometrics to neuroscience. Biol Cybern 105:183\u2013195", "ArticleIdList": ["10.1007/s00422-011-0456-4", "22095173"]}, {"Citation": "Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, Cotelli M, Gennarelli M, Binetti G, Bocchio L, Paghera B (2009) Markers of Alzheimer\u2019s disease in a population attending a memory clinic. Alzheimers Dement 5(4):307\u2013317", "ArticleIdList": ["10.1016/j.jalz.2009.04.1235", "19560101"]}, {"Citation": "Moretti D, Frisoni GB, Fracassi C, Pievani M, Geroldi C, Binetti G, Rossini PM, Zanetti O (2011) MCI patients\u2019 EEGs show group differences between those who progress and those who do not progress to AD. Neurobiol Aging 32(4):563\u2013571", "ArticleIdList": ["10.1016/j.neurobiolaging.2009.04.003", "20022139"]}, {"Citation": "Moretti D, Paternic\u00f2 D, Binetti G, Zanetti O, Frisoni GB (2012) EEG markers are associated to gray matter changes in thalamus and basal ganglia in subjects with mild cognitive impairment. Neuroimage 60(1):489\u2013496", "ArticleIdList": ["10.1016/j.neuroimage.2011.11.086", "22166796"]}, {"Citation": "Moretti D, Pievani M, Geroldi C, Binetti G, Zanetti O, Rossini P, Frisoni G (2010) EEG markers discriminate among different subgroup of patients with mild cognitive impairment. Am J Alzheimers Dis Other Dement 25(1):58\u201373", "ArticleIdList": ["10.1177/1533317508329814"]}, {"Citation": "Moretti DV, Zanetti O, Binetti G, Frisoni GB (2012) Quantitative EEG markers in mild cognitive impairment: degenerative versus vascular brain impairment. Int J Alzheimers Dis 2012:917537. https://doi.org/10.1155/2012/917537"}, {"Citation": "Zhang S, Chiang-shan RL (2012) Functional connectivity mapping of the human precuneus by resting state fMRI. Neuroimage 59(4):3548\u20133562", "ArticleIdList": ["10.1016/j.neuroimage.2011.11.023", "22116037"]}, {"Citation": "Garc\u00e9s P, Pineda-Pardo J\u00c1, Canuet L, Aurtenetxe S, L\u00f3pez ME, Marcos A, Yus M, Llanero-Luque M, Del-Pozo F, Sancho M (2014) The Default Mode Network is functionally and structurally disrupted in amnestic mild cognitive impairment\u2014A bimodal MEG\u2013DTI study. NeuroImage: Clin 6:214\u2013221", "ArticleIdList": ["10.1016/j.nicl.2014.09.004", "25379433"]}, {"Citation": "Montez T, Poil S-S, Jones BF, Manshanden I, Verbunt JP, van Dijk BW, Brussaard AB, van Ooyen A, Stam CJ, Scheltens P (2009) Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer disease. Proc Natl Acad Sci 106(5):1614\u20131619", "ArticleIdList": ["10.1073/pnas.0811699106", "19164579", "2635782"]}, {"Citation": "Cantero JL, Atienza M, Cruz-Vadell A, Suarez-Gonzalez A, Gil-Neciga E (2009) Increased synchronization and decreased neural complexity underlie thalamocortical oscillatory dynamics in mild cognitive impairment. Neuroimage 46(4):938\u2013948", "ArticleIdList": ["10.1016/j.neuroimage.2009.03.018", "19303446"]}, {"Citation": "Moretti DV, Babiloni C, Binetti G, Cassetta E, Dal Forno G, Ferreric F, Ferri R, Lanuzza B, Miniussi C, Nobili F (2004) Individual analysis of EEG frequency and band power in mild Alzheimer\u2019s disease. Clin Neurophysiol 115(2):299\u2013308", "ArticleIdList": ["10.1016/S1388-2457(03)00345-6", "14744569"]}, {"Citation": "Hammond C, Bergman H, Brown P (2007) Pathological synchronization in Parkinson\u2019s disease: networks, models and treatments. Trends Neurosci 30(7):357\u2013364. https://doi.org/10.1016/j.tins.2007.05.004", "ArticleIdList": ["10.1016/j.tins.2007.05.004", "17532060"]}, {"Citation": "Little S, Brown P (2014) The functional role of beta oscillations in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1):S44-48. https://doi.org/10.1016/S1353-8020(13)70013-0", "ArticleIdList": ["10.1016/S1353-8020(13)70013-0", "24262186"]}, {"Citation": "Koelewijn L, Bompas A, Tales A, Brookes MJ, Muthukumaraswamy SD, Bayer A, Singh KD (2017) Alzheimer\u2019s disease disrupts alpha and beta-band resting-state oscillatory network connectivity. Clin Neurophysiol 128(11):2347\u20132357. https://doi.org/10.1016/j.clinph.2017.04.018", "ArticleIdList": ["10.1016/j.clinph.2017.04.018", "28571910", "5674981"]}, {"Citation": "Proudfoot M, van Ede F, Quinn A, Colclough GL, Wuu J, Talbot K, Benatar M, Woolrich MW, Nobre AC, Turner MR (2018) Impaired corticomuscular and interhemispheric cortical beta oscillation coupling in amyotrophic lateral sclerosis. Clin Neurophysiol 129(7):1479\u20131489. https://doi.org/10.1016/j.clinph.2018.03.019", "ArticleIdList": ["10.1016/j.clinph.2018.03.019", "29678369"]}, {"Citation": "Osipova D, Ahveninen J, Jensen O, Ylikoski A, Pekkonen E (2005) Altered generation of spontaneous oscillations in Alzheimer\u2019s disease. Neuroimage 27(4):835\u2013841. https://doi.org/10.1016/j.neuroimage.2005.05.011", "ArticleIdList": ["10.1016/j.neuroimage.2005.05.011", "15961323"]}, {"Citation": "Hsiao FJ, Wang YJ, Yan SH, Chen WT, Lin YY (2013) Altered oscillation and synchronization of default-mode network activity in mild Alzheimer\u2019s disease compared to mild cognitive impairment: an electrophysiological study. PLoS ONE 8(7):e68792. https://doi.org/10.1371/journal.pone.0068792", "ArticleIdList": ["10.1371/journal.pone.0068792", "23874766", "3708894"]}, {"Citation": "Stam CJ, Montez T, Jones BF, Rombouts SA, van der Made Y, Pijnenburg YA, Scheltens P (2005) Disturbed fluctuations of resting state EEG synchronization in Alzheimer\u2019s disease. Clin Neurophysiol 116(3):708\u2013715. https://doi.org/10.1016/j.clinph.2004.09.022", "ArticleIdList": ["10.1016/j.clinph.2004.09.022", "15721085"]}, {"Citation": "Fjell AM, Westlye LT, Amlien IK, Walhovd KB (2011) Reduced white matter integrity is related to cognitive instability. J Neurosci 31(49):18060\u201318072. https://doi.org/10.1523/JNEUROSCI.4735-11.2011", "ArticleIdList": ["10.1523/JNEUROSCI.4735-11.2011", "22159119", "6634144"]}, {"Citation": "Fraga FJ, Falk TH, Kanda PA, Anghinah R (2013) Characterizing Alzheimer\u2019s disease severity via resting-awake EEG amplitude modulation analysis. PLoS ONE 8(8):e72240. https://doi.org/10.1371/journal.pone.0072240", "ArticleIdList": ["10.1371/journal.pone.0072240", "24015222", "3754998"]}, {"Citation": "Kwak YT (2006) Quantitative EEG findings in different stages of Alzheimer\u2019s disease. J Clin Neurophysiol 23(5):456\u2013461. https://doi.org/10.1097/01.wnp.0000223453.47663.63", "ArticleIdList": ["10.1097/01.wnp.0000223453.47663.63", "17016157"]}, {"Citation": "Horvath A, Szucs A, Csukly G, Sakovics A, Stefanics G, Kamondi A (2018) EEG and ERP biomarkers of Alzheimer\u2019s disease: a critical review. Front Biosci (Landmark Ed) 23(2):183\u2013220. https://doi.org/10.2741/4587", "ArticleIdList": ["10.2741/4587", "28930543"]}, {"Citation": "Rossini PM, Di Iorio R, Vecchio F, Anfossi M, Babiloni C, Bozzali M, Bruni AC, Cappa SF, Escudero J, Fraga FJ, Giannakopoulos P, Guntekin B, Logroscino G, Marra C, Miraglia F, Panza F, Tecchio F, Pascual-Leone A, Dubois B (2020) Early diagnosis of Alzheimer\u2019s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts. Clin Neurophysiol 131(6):1287\u20131310. https://doi.org/10.1016/j.clinph.2020.03.003", "ArticleIdList": ["10.1016/j.clinph.2020.03.003", "32302946"]}, {"Citation": "Babiloni C, Del Percio C, Boccardi M, Lizio R, Lopez S, Carducci F, Marzano N, Soricelli A, Ferri R, Triggiani AI, Prestia A, Salinari S, Rasser PE, Basar E, Fama F, Nobili F, Yener G, Emek-Savas DD, Gesualdo L, Mundi C, Thompson PM, Rossini PM, Frisoni GB (2015) Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging 36(2):556\u2013570. https://doi.org/10.1016/j.neurobiolaging.2014.09.011", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.09.011", "25442118"]}, {"Citation": "Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fernandez A, Frisoni G, Guntekin B, Hajos M, Hampel H, Ifeachor E, Kilborn K, Kumar S, Johnsen K, Johannsson M, Jeong J, LeBeau F, Lizio R, Lopes da Silva F, Maestu F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Olichney J, Onofrj M, Palop JJ, Rowan M, Stocchi F, Struzik ZM, Tanila H, Teipel S, Taylor JP, Weiergraber M, Yener G, Young-Pearse T, Drinkenburg WH, Randall F (2020) What electrophysiology tells us about Alzheimer\u2019s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging 85:58\u201373. https://doi.org/10.1016/j.neurobiolaging.2019.09.008", "ArticleIdList": ["10.1016/j.neurobiolaging.2019.09.008", "31739167"]}, {"Citation": "Lopez-Sanz D, Bruna R, Garces P, Camara C, Serrano N, Rodriguez-Rojo IC, Delgado ML, Montenegro M, Lopez-Higes R, Yus M, Maestu F (2016) Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study. Sci Rep 6:37685. https://doi.org/10.1038/srep37685", "ArticleIdList": ["10.1038/srep37685", "27883082", "5121589"]}, {"Citation": "Hier DB, Mangone CA, Ganellen R, Warach JD, Van Egeren R, Perlik SJ, Gorelick PB (1991) Quantitative measurement of delta activity in Alzheimer\u2019s disease. Clin Electroencephalogr 22(3):178\u2013182. https://doi.org/10.1177/155005949102200309", "ArticleIdList": ["10.1177/155005949102200309", "1879056"]}, {"Citation": "Babiloni C, Ferri R, Noce G, Lizio R, Lopez S, Soricelli A, Nobili F, Arnaldi D, Fama F, Orzi F, Buttinelli C, Giubilei F, Cipollini V, Marizzoni M, Guntekin B, Akturk T, Hanoglu L, Yener G, Emek-Savas DD, Stocchi F, Vacca L, Frisoni GB, Del Percio C (2020) Resting-state electroencephalographic delta rhythms may reflect global cortical arousal in healthy old seniors and patients with Alzheimer\u2019s disease dementia. Int J Psychophysiol 158:259\u2013270. https://doi.org/10.1016/j.ijpsycho.2020.08.012", "ArticleIdList": ["10.1016/j.ijpsycho.2020.08.012", "33080295"]}, {"Citation": "Moretti DV, Babiloni C, Binetti G, Cassetta E, Dal Forno G, Ferreric F, Ferri R, Lanuzza B, Miniussi C, Nobili F, Rodriguez G, Salinari S, Rossini PM (2004) Individual analysis of EEG frequency and band power in mild Alzheimer\u2019s disease. Clin Neurophysiol 115(2):299\u2013308. https://doi.org/10.1016/s1388-2457(03)00345-6", "ArticleIdList": ["10.1016/s1388-2457(03)00345-6", "14744569"]}, {"Citation": "Silman I, Sussman JL (2005) Acetylcholinesterase: \u201cclassical\u201d and \u201cnon-classical\u201d functions and pharmacology. Curr Opin Pharmacol 5(3):293\u2013302. https://doi.org/10.1016/j.coph.2005.01.014", "ArticleIdList": ["10.1016/j.coph.2005.01.014", "15907917"]}, {"Citation": "Bartus RT, Dean RL 3rd, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408\u2013414. https://doi.org/10.1126/science.7046051", "ArticleIdList": ["10.1126/science.7046051", "7046051"]}, {"Citation": "Grutzendler J, Morris JC (2001) Cholinesterase inhibitors for Alzheimer\u2019s disease. Drugs 61(1):41\u201352. https://doi.org/10.2165/00003495-200161010-00005", "ArticleIdList": ["10.2165/00003495-200161010-00005", "11217870"]}, {"Citation": "Huang Z, Jordan JD, Zhang Q (2023) Myelin Pathology in Alzheimer\u2019s Disease: Potential Therapeutic Opportunities. Aging Dis. https://doi.org/10.14336/AD.2023.0628", "ArticleIdList": ["10.14336/AD.2023.0628", "38029398", "10529745"]}, {"Citation": "Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E (2001) Nicotinic receptor abnormalities in Alzheimer\u2019s disease. Biol Psychiatry 49(3):175\u2013184. https://doi.org/10.1016/s0006-3223(00)01116-1", "ArticleIdList": ["10.1016/s0006-3223(00)01116-1", "11230868"]}, {"Citation": "Court JA, Martin-Ruiz C, Graham A, Perry E (2000) Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat 20(3\u20134):281\u2013298", "ArticleIdList": ["10.1016/S0891-0618(00)00110-1", "11207426"]}, {"Citation": "Aarsland D, Mosimann UP, McKeith IG (2004) Role of cholinesterase inhibitors in Parkinson\u2019s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17(3):164\u2013171", "ArticleIdList": ["10.1177/0891988704267463", "15312280"]}, {"Citation": "Lane RM, Potkin SG, Enz A (2006) Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 9(1):101\u2013124", "ArticleIdList": ["10.1017/S1461145705005833", "16083515"]}, {"Citation": "Cui X, Guo YE, Fang JH, Shi CJ, Suo N, Zhang R, Xie X (2019) Donepezil, a drug for Alzheimer\u2019s disease, promotes oligodendrocyte generation and remyelination. Acta Pharmacol Sin 40(11):1386\u20131393. https://doi.org/10.1038/s41401-018-0206-4", "ArticleIdList": ["10.1038/s41401-018-0206-4", "30918344", "6888883"]}, {"Citation": "Tabet N (2006) Acetylcholinesterase inhibitors for Alzheimer\u2019s disease: anti-inflammatories in acetylcholine clothing! Age Ageing 35(4):336\u2013338. https://doi.org/10.1093/ageing/afl027", "ArticleIdList": ["10.1093/ageing/afl027", "16788077"]}, {"Citation": "Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer\u2019s disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68(3):209\u2013245. https://doi.org/10.1016/s0301-0082(02)00079-5", "ArticleIdList": ["10.1016/s0301-0082(02)00079-5", "12450488"]}, {"Citation": "Dringenberg HC (2000) Alzheimer\u2019s disease: more than a \u201ccholinergic disorder\u201d - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115(2):235\u2013249. https://doi.org/10.1016/s0166-4328(00)00261-8", "ArticleIdList": ["10.1016/s0166-4328(00)00261-8", "11000423"]}, {"Citation": "Jin N, Gureviciene I, Atalay AN, H\u00e4kli S, Ziyatdinova S, Tanila H (2022) Preclinical evaluation of drug treatment options for sleep-related epileptiform spiking in Alzheimer\u2019s disease. Alzheimers Dement: Transl Res Clin Interv 8(1):e12291", "ArticleIdList": ["10.1002/trc2.12291"]}, {"Citation": "Kaniakova M, Nepovimova E, Kleteckova L, Skrenkova K, Holubova K, Chrienova Z, Hepnarova V, Kucera T, Kobrlova T, Vales K (2019) Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer\u2019s disease. Curr Alzheimer Res 16(9):821\u2013833", "ArticleIdList": ["10.2174/1567205016666190228122218", "30819076"]}, {"Citation": "Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Group MS, Group MS (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291(3):317\u2013324", "ArticleIdList": ["10.1001/jama.291.3.317", "14734594"]}, {"Citation": "Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT (2008) Memantine treatment in patients with mild to moderate Alzheimer\u2019s disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 5(1):83\u201389", "ArticleIdList": ["10.2174/156720508783884576", "18288936"]}, {"Citation": "Nguyen HD (2022) Combination of donepezil and memantine attenuated cognitive impairment induced by mixed endocrine-disrupting chemicals: an in silico study. Neurotox Res 40:2072\u20132088. https://doi.org/10.1007/s12640-022-00591-7"}, {"Citation": "Babiloni C, Del Percio C, Bordet R, Bourriez J-L, Bentivoglio M, Payoux P, Derambure P, Dix S, Infarinato F, Lizio R (2013) Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer\u2019s disease patients. Clin Neurophysiol 124(5):837\u2013850", "ArticleIdList": ["10.1016/j.clinph.2012.09.017", "23098644"]}, {"Citation": "Arce MP, Rodriguez-Franco MI, Gonzalez-Munoz GC, Perez C, Lopez B, Villarroya M, Lopez MG, Garcia AG, Conde S (2009) Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer\u2019s disease. J Med Chem 52(22):7249\u20137257. https://doi.org/10.1021/jm900628z", "ArticleIdList": ["10.1021/jm900628z", "19856923"]}, {"Citation": "Castro A, Martinez A (2006) Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. Curr Pharm Des 12(33):4377\u20134387. https://doi.org/10.2174/138161206778792985", "ArticleIdList": ["10.2174/138161206778792985", "17105433"]}, {"Citation": "Desai AK, Grossberg GT (2005) Rivastigmine for Alzheimer\u2019s disease. Expert Rev Neurother 5(5):563\u2013580. https://doi.org/10.1586/14737175.5.5.563", "ArticleIdList": ["10.1586/14737175.5.5.563", "16162080"]}, {"Citation": "Bartolucci C, Perola E, Pilger C, Fels G, Lamba D (2001) Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs. Proteins 42(2):182\u2013191. https://doi.org/10.1002/1097-0134(20010201)42:2%3c182::aid-prot50%3e3.0.co;2-1", "ArticleIdList": ["10.1002/1097-0134(20010201)42:2<182::aid-prot50>3.0.co;2-1", "11119642"]}, {"Citation": "Kitisripanya N, Saparpakorn P, Wolschann P, Hannongbua S (2011) Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method. Nanomedicine 7(1):60\u201368. https://doi.org/10.1016/j.nano.2010.08.004", "ArticleIdList": ["10.1016/j.nano.2010.08.004", "20851778"]}, {"Citation": "Wessler I, Kirkpatrick CJ (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154(8):1558\u20131571. https://doi.org/10.1038/bjp.2008.185", "ArticleIdList": ["10.1038/bjp.2008.185", "18500366", "2518461"]}, {"Citation": "Pohanka M (2011) Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155(3):219\u2013229. https://doi.org/10.5507/bp.2011.036", "ArticleIdList": ["10.5507/bp.2011.036", "22286807"]}, {"Citation": "Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11(3):315\u2013335. https://doi.org/10.2174/1570159X11311030006", "ArticleIdList": ["10.2174/1570159X11311030006", "24179466", "3648782"]}, {"Citation": "Cacabelos R (2020) Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. Expert Opin Drug Metab Toxicol 16(8):673\u2013701. https://doi.org/10.1080/17425255.2020.1779700", "ArticleIdList": ["10.1080/17425255.2020.1779700", "32520597"]}, {"Citation": "Bonner LT, Peskind ER (2002) Pharmacologic treatments of dementia. Med Clin North Am 86(3):657\u2013674. https://doi.org/10.1016/s0025-7125(02)00007-x", "ArticleIdList": ["10.1016/s0025-7125(02)00007-x", "12171061"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "21"}, {"Year": "2023", "Month": "10", "Day": "1"}, {"Year": "2024", "Month": "1", "Day": "18", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "10", "Day": "16", "Hour": "12", "Minute": "41"}, {"Year": "2023", "Month": "10", "Day": "16", "Hour": "11", "Minute": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37843690", "10.1007/s10072-023-07114-y", "10.1007/s10072-023-07114-y"]}}], "PubmedBookArticle": []}